Michael Mingzhao Xing

Professor

1992 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Michael Mingzhao Xing is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 5 Similar Profiles
Thyroid Neoplasms Medicine & Life Sciences
Mutation Medicine & Life Sciences
Proto-Oncogene Proteins B-raf Medicine & Life Sciences
Thyroid Gland Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Methylation Medicine & Life Sciences
Tumors Chemical Compounds
Phosphatidylinositol 3-Kinase Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1992 2019

Entering an Era of Precision Management of Thyroid Cancer

Xing, M. M., Mar 1 2019, In : Endocrinology and Metabolism Clinics of North America. 48, 1, p. xvii-xviii

Research output: Contribution to journalEditorial

Thyroid Neoplasms

Genetic-guided Risk Assessment and Management of Thyroid Cancer

Xing, M. M., Mar 1 2019, In : Endocrinology and Metabolism Clinics of North America. 48, 1, p. 109-124 16 p.

Research output: Contribution to journalReview article

Risk Management
Thyroid Neoplasms
Genetic Markers
Mutation
Genotype

Identification and characterization of two novel oncogenic mTOR mutations

Murugan, A. K., Liu, R. & Xing, M. M., Jan 1 2019, In : Oncogene.

Research output: Contribution to journalArticle

Sirolimus
Mutation
Neoplasms
Melanoma
70-kDa Ribosomal Protein S6 Kinases

BRAF V600E confers male sex disease-specific mortality risk in patients with papillary thyroid cancer

Wang, F., Zhao, S., Shen, X., Zhu, G., Liu, R., Viola, D., Elisei, R., Puxeddu, E., Fugazzola, L., Colombo, C., Jarzab, B., Czarniecka, A., Lam, A. K., Mian, C., Vianello, F., Yip, L., Riesco-Eizaguirre, G., Santisteban, P., O’Neill, C. J., Sywak, M. S. & 5 others, Clifton-Bligh, R., Bendlova, B., Sýkorová, V., Wang, Y. & Xing, M. M., Sep 20 2018, In : Journal of Clinical Oncology. 36, 27, p. 2787-2795 9 p.

Research output: Contribution to journalArticle

Mortality
Papillary Thyroid cancer
Neoplasm Metastasis

BRAF V600E mutation-assisted risk stratification of solitary intrathyroidal papillary thyroid cancer for precision treatment

Huang, Y., Qu, S., Zhu, G., Wang, F., Liu, R., Shen, X., Viola, D., Elisei, R., Puxeddu, E., Fugazzola, L., Colombo, C., Jarzab, B., Czarniecka, A., Lam, A. K., Mian, C., Vianello, F., Yip, L., Riesco-Eizaguirre, G., Santisteban, P., O'Neill, C. J. & 1 others, Xing, M. M., Apr 1 2018, In : Journal of the National Cancer Institute. 110, 4

Research output: Contribution to journalArticle

Mutation
Recurrence
Confidence Intervals
Therapeutics
Factor IX